Alithea Genomics introduces MERCURIUS™ Spheroid DRUG-seq: extraction-free, RNA-seq for 3D drug scree...

October 9, 2025

Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel...

Lonza expands its TheraPEAK® product portfolio with the addition of AmpliCell® Cytokine range and Th...

October 6, 2025

AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-...

PromoCell enters the GMP field with custom cell culture media services for cell-based therapy and r...

September 30, 2025

New offering to debut at 32nd ESGCT Congress, October 7–10 in Seville, Spain PromoCell GmbH, a leading global manufacturer of primary human cells and ...

Newsroom

Categories

Choose a Category

Subscribe to Email Updates

Formedix launches community forum and resource hub to support clinical trial industry

READ MORE

Revolutionary “sugar soap” CAVADEX reverses cholesterol blocked arteries in a matter of months

READ MORE

WAPG and Astellas Announce Future Innovator Prize to Help Emerging Biotechs Accelerate Early Drug Discovery & Research Efforts

READ MORE

Brooks Automation and Cleveland Clinic celebrate opening of biobanking facility

READ MORE

Xuanzhu and SignalChem Lifesciences Corporation announce collaboration and licensing agreement for SLC-391 in the Greater China region

READ MORE

IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)

READ MORE

Biotium launches optimized solution for exosome detection by flow cytometry

READ MORE

Glyscend Therapeutics announces preclinical data at ADA 2021 on the metabolic benefits of its oral polymer-based duodenal exclusion therapy

READ MORE

The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial

READ MORE

Browse more news

Recent releases

Alithea Genomics introduces MERCURIUS™ Spheroid DRUG-seq: extraction-free, RNA-seq for 3D drug scree...

READ MORE

Lonza expands its TheraPEAK® product portfolio with the addition of AmpliCell® Cytokine range and Th...

READ MORE

PromoCell enters the GMP field with custom cell culture media services for cell-based therapy and r...

READ MORE

Useful information